Skip to main content
OpenTrials

Clinical trial condition

Other Squamous Cell Carcinoma (SCC) With HRAS Mutant Tumor

Explore clinical trials studying Other Squamous Cell Carcinoma (SCC) With HRAS Mutant Tumor. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Other Squamous Cell Carcinoma (SCC) With HRAS Mutant Tumor trial results

Completed

Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations

NCT02383927

Conditions
Carcinoma, Carcinoma, Squamous Cell, Endocrine Gland Neoplasms, +13 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • Wihship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View all 35 locations
View Trial Details

Related conditions